Trial Profile
Clinical study of Hematide in chronic renal failure patients on hemodialysis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 May 2017
Price :
$35
*
At a glance
- Drugs Peginesatide (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Takeda
- 27 May 2016 New trial record